Fever - Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Fever - Pipeline Review, H1 2012', provides an overview of the Fever therapeutic pipeline. This report provides information on the therapeutic development for Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fever. 'Fever - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- A snapshot of the global therapeutic scenario for Fever.
- A review of the Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Fever pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy- Identify and understand important and diverse types of therapeutics under development for Fever.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Fever pipeline depth and focus of Fever therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
|
- Introduction
- Global Markets Direct Report Coverage
- Fever Overview
- Therapeutics Development
- An Overview of Pipeline Products for Fever
- Fever Therapeutics under Development by Companies
- Fever Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Fever Therapeutics - Products under Development by Companies
- Fever Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Fever Therapeutics Development
- Cangene Corporation
- Novartis AG
- AVI BioPharma Inc.
- NeurogesX, Inc.
- Ahn-Gook Pharmaceutical Co., Ltd.
- PLx Pharma Inc.
- Inviragen, Inc.
- Fever - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Ilaris - Drug Profile
- mPGES-1 Inhibitor - Drug Profile
- AVI-6002 - Drug Profile
- AVI-6003 - Drug Profile
- NGX-1576 - Drug Profile
- NGX-9674 - Drug Profile
- NGX-5752 - Drug Profile
- PL 2200 Aspirin - Drug Profile
- MK-0991 - Drug Profile
- Daptomycin - Drug Profile
- DENVax - Drug Profile
- AG NDP803 - Drug Profile
- Liposomal Amphotericin B - Drug Profile
- Micafungin - Drug Profile
- Invaplex 50 Vaccine - Drug Profile
- Ebola/Marburg Immune Globulins - Drug Profile
- Daptomycin - Drug Profile
- NanoActive Ibuprofen - Drug Profile
- Rotavin-M1 - Drug Profile
- Rotavin-M1 - Drug Profile
- Fever Therapeutics - Drug Profile Updates
- Fever Therapeutics - Discontinued Products
- Fever Therapeutics - Dormant Products
- Fever - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products Under Development for Fever, H1 2012
- Products under Development for Fever - Comparative Analysis, H1 2012
- Number of Products under Development by Companies, H1 2012
- Number of Products under Investigation by Universities/Institutes, H1 2012
- Comparative Analysis by Late Stage Development, H1 2012
- Comparative Analysis by Mid Clinical Stage Development, H1 2012
- Comparative Analysis by Early Clinical Stage Development, H1 2012
- Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2012
- Products under Development by Companies, H1 2012
- Products under Investigation by Universities/Institutes, H1 2012
- Cangene Corporation, H1 2012
- Novartis AG, H1 2012
- AVI BioPharma Inc., H1 2012
- NeurogesX, Inc., H1 2012
- Ahn-Gook Pharmaceutical Co., Ltd., H1 2012
- PLx Pharma Inc., H1 2012
- Inviragen, Inc., H1 2012
- Assessment by Monotherapy Products, H1 2012
- Assessment by Stage and Route of Administration, H1 2012
- Assessment by Molecule Type, H1 2012
- Fever Therapeutics - Drug Profile Updates
- Fever Therapeutics - Discontinued Products
- Fever Therapeutics - Dormant Products
- List of Figures
- Number of Products under Development for Fever, H1 2012
- Products under Development for Fever - Comparative Analysis, H1 2012
- Products under Development by Companies, H1 2012
- Products under Investigation by Universities/Institutes, H1 2012
- Late Stage Products, H1 2012
- Mid Clinical Stage Products, H1 2012
- Early Clinical Stage Products, H1 2012
- Discovery and Pre-Clinical Stage Products, H1 2012
- Assessment by Monotherapy Products, H1 2012
- Assessment by Route of Administration, H1 2012
- Assessment by Stage and Route of Administration, H1 2012
- Assessment by Molecule Type, H1 2012
- Assessment by Stage and Molecule Type, H1 2012
Share this report
Other tasks Related Markets Drug Discovery Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
